Affinity DataKi: 0.00300nMAssay Description:In vitro inhibition constant (Ki) against human thrombinMore data for this Ligand-Target Pair
Affinity DataKi: 0.00300nMAssay Description:In vitro inhibition constant (Ki) against human thrombinMore data for this Ligand-Target Pair
Affinity DataKi: 0.00400nMAssay Description:In vitro inhibition constant (Ki) against human thrombinMore data for this Ligand-Target Pair
Affinity DataKi: 0.00500nMAssay Description:In vitro inhibition constant (Ki) against human thrombinMore data for this Ligand-Target Pair
Affinity DataKi: 0.00800nMAssay Description:In vitro inhibition constant (Ki) against human thrombinMore data for this Ligand-Target Pair
Affinity DataKi: 0.0100nMAssay Description:In vitro inhibition constant (Ki) against human thrombinMore data for this Ligand-Target Pair
Affinity DataKi: 0.0100nMAssay Description:In vitro inhibition constant (Ki) against human thrombinMore data for this Ligand-Target Pair
Affinity DataKi: 0.0130nMAssay Description:In vitro inhibition constant (Ki) against human thrombinMore data for this Ligand-Target Pair
Affinity DataKi: 0.0150nMAssay Description:In vitro inhibition constant (Ki) against human thrombinMore data for this Ligand-Target Pair
Affinity DataKi: 0.0150nMAssay Description:In vitro inhibition constant (Ki) against human thrombinMore data for this Ligand-Target Pair
Affinity DataKi: 0.0150nMAssay Description:In vitro inhibition constant (Ki) against human thrombinMore data for this Ligand-Target Pair
Affinity DataKi: 0.0170nMAssay Description:In vitro inhibition constant (Ki) against human thrombinMore data for this Ligand-Target Pair
Affinity DataKi: 0.0200nMAssay Description:In vitro inhibition constant (Ki) against human thrombinMore data for this Ligand-Target Pair
Affinity DataKi: 0.0200nMAssay Description:In vitro inhibition constant (Ki) against human thrombinMore data for this Ligand-Target Pair
Affinity DataKi: 0.0300nMAssay Description:In vitro inhibition constant (Ki) against human thrombinMore data for this Ligand-Target Pair
Affinity DataKi: 0.100nMAssay Description:In vitro inhibition constant (Ki) against human thrombinMore data for this Ligand-Target Pair
Affinity DataKi: 0.120nMAssay Description:In vitro inhibition constant (Ki) against human thrombinMore data for this Ligand-Target Pair
Affinity DataKi: 0.160nMAssay Description:In vitro inhibition constant (Ki) against human thrombinMore data for this Ligand-Target Pair
Affinity DataKi: 0.170nMAssay Description:In vitro inhibition constant (Ki) against human thrombinMore data for this Ligand-Target Pair
Affinity DataKi: 0.300nMAssay Description:In vitro inhibition constant (Ki) against human human trypsin was determinedMore data for this Ligand-Target Pair
Affinity DataKi: 0.400nMAssay Description:In vitro inhibition constant (Ki) against human thrombinMore data for this Ligand-Target Pair
Affinity DataKi: 0.430nMAssay Description:In vitro inhibition constant (Ki) against human thrombinMore data for this Ligand-Target Pair
Affinity DataKi: 0.600nMAssay Description:In vitro inhibition constant (Ki) against human thrombinMore data for this Ligand-Target Pair
Affinity DataKi: 0.640nMAssay Description:In vitro inhibition constant (Ki) against human thrombinMore data for this Ligand-Target Pair
Affinity DataKi: 1.40nMAssay Description:In vitro inhibition constant (Ki) against human thrombinMore data for this Ligand-Target Pair
Affinity DataKi: 3nMAssay Description:In vitro inhibition constant (Ki) against human bovine trypsin was determinedMore data for this Ligand-Target Pair
Affinity DataKi: 4nMAssay Description:In vitro inhibition constant (Ki) against human thrombinMore data for this Ligand-Target Pair
Affinity DataKi: 22.5nMAssay Description:In vitro inhibition constant (Ki) against human Coagulation factor X was determinedMore data for this Ligand-Target Pair
Affinity DataKi: 433nMAssay Description:In vitro inhibition constant (Ki) against human Tissue type plasminogen activator was determinedMore data for this Ligand-Target Pair
Affinity DataKi: 7.40E+3nMAssay Description:In vitro inhibition constant (Ki) against human human plasmin was determinedMore data for this Ligand-Target Pair
TargetEstrogen-related receptor gamma(Homo sapiens (Human))
Daegu-Gyeongbuk Medical Innovation Foundation
Curated by ChEMBL
Daegu-Gyeongbuk Medical Innovation Foundation
Curated by ChEMBL
Affinity DataIC50: 20nMAssay Description:Inhibition of fluorescien-conjugated coactivator PGC1a binding to GST-tagged human ERRgamma LBD after 1 hr by TR-FRET assayMore data for this Ligand-Target Pair
TargetEstrogen receptor(Homo sapiens (Human))
Daegu-Gyeongbuk Medical Innovation Foundation
Curated by ChEMBL
Daegu-Gyeongbuk Medical Innovation Foundation
Curated by ChEMBL
Affinity DataIC50: 20nMAssay Description:Inhibition of fluorescien-conjugated coactivator PGC1a binding to ERalpha (unknown origin) after 1 hr by TR-FRET assayMore data for this Ligand-Target Pair
TargetEstrogen-related receptor gamma(Homo sapiens (Human))
Daegu-Gyeongbuk Medical Innovation Foundation
Curated by ChEMBL
Daegu-Gyeongbuk Medical Innovation Foundation
Curated by ChEMBL
Affinity DataIC50: 48nMAssay Description:Inverse agonist activity at ERRgamma (unknown origin) expressed in human AD293 cells after 24 hrs by beta-galactosidase/luciferase reporter gene assa...More data for this Ligand-Target Pair
TargetEstrogen-related receptor gamma(Homo sapiens (Human))
Daegu-Gyeongbuk Medical Innovation Foundation
Curated by ChEMBL
Daegu-Gyeongbuk Medical Innovation Foundation
Curated by ChEMBL
Affinity DataIC50: 58nMAssay Description:Inverse agonist activity at ERRgamma (unknown origin) expressed in human AD293 cells after 24 hrs by beta-galactosidase/luciferase reporter gene assa...More data for this Ligand-Target Pair
TargetEstrogen-related receptor gamma(Homo sapiens (Human))
Daegu-Gyeongbuk Medical Innovation Foundation
Curated by ChEMBL
Daegu-Gyeongbuk Medical Innovation Foundation
Curated by ChEMBL
Affinity DataIC50: 77nMAssay Description:Inverse agonist activity at ERRgamma (unknown origin) expressed in human AD293 cells after 24 hrs by beta-galactosidase/luciferase reporter gene assa...More data for this Ligand-Target Pair
TargetEstrogen-related receptor gamma(Homo sapiens (Human))
Daegu-Gyeongbuk Medical Innovation Foundation
Curated by ChEMBL
Daegu-Gyeongbuk Medical Innovation Foundation
Curated by ChEMBL
Affinity DataIC50: 79nMAssay Description:Inverse agonist activity at ERRgamma (unknown origin) expressed in human AD293 cells after 24 hrs by beta-galactosidase/luciferase reporter gene assa...More data for this Ligand-Target Pair
TargetEstrogen-related receptor gamma(Homo sapiens (Human))
Daegu-Gyeongbuk Medical Innovation Foundation
Curated by ChEMBL
Daegu-Gyeongbuk Medical Innovation Foundation
Curated by ChEMBL
Affinity DataIC50: 90nMAssay Description:Inhibition of fluorescien-conjugated coactivator PGC1a binding to GST-tagged human ERRgamma LBD after 1 hr by TR-FRET assayMore data for this Ligand-Target Pair
TargetEstrogen-related receptor gamma(Homo sapiens (Human))
Daegu-Gyeongbuk Medical Innovation Foundation
Curated by ChEMBL
Daegu-Gyeongbuk Medical Innovation Foundation
Curated by ChEMBL
Affinity DataIC50: 110nMAssay Description:Inhibition of fluorescien-conjugated coactivator PGC1a binding to GST-tagged human ERRgamma LBD after 1 hr by TR-FRET assayMore data for this Ligand-Target Pair
TargetEstrogen-related receptor gamma(Homo sapiens (Human))
Daegu-Gyeongbuk Medical Innovation Foundation
Curated by ChEMBL
Daegu-Gyeongbuk Medical Innovation Foundation
Curated by ChEMBL
Affinity DataIC50: 111nMAssay Description:Inverse agonist activity at ERRgamma (unknown origin) expressed in human AD293 cells after 24 hrs by beta-galactosidase/luciferase reporter gene assa...More data for this Ligand-Target Pair
TargetEstrogen-related receptor gamma(Homo sapiens (Human))
Daegu-Gyeongbuk Medical Innovation Foundation
Curated by ChEMBL
Daegu-Gyeongbuk Medical Innovation Foundation
Curated by ChEMBL
Affinity DataIC50: 117nMAssay Description:Inhibition of fluorescien-conjugated coactivator PGC1a binding to GST-tagged human ERRgamma LBD after 1 hr by TR-FRET assayMore data for this Ligand-Target Pair
TargetEstrogen-related receptor gamma(Homo sapiens (Human))
Daegu-Gyeongbuk Medical Innovation Foundation
Curated by ChEMBL
Daegu-Gyeongbuk Medical Innovation Foundation
Curated by ChEMBL
Affinity DataIC50: 180nMAssay Description:Inhibition of fluorescien-conjugated coactivator PGC1a binding to GST-tagged human ERRgamma LBD after 1 hr by TR-FRET assayMore data for this Ligand-Target Pair
TargetEstrogen-related receptor gamma(Homo sapiens (Human))
Daegu-Gyeongbuk Medical Innovation Foundation
Curated by ChEMBL
Daegu-Gyeongbuk Medical Innovation Foundation
Curated by ChEMBL
Affinity DataIC50: 187nMAssay Description:Inverse agonist activity at ERRgamma (unknown origin) expressed in human AD293 cells after 24 hrs by beta-galactosidase/luciferase reporter gene assa...More data for this Ligand-Target Pair
TargetEstrogen-related receptor gamma(Homo sapiens (Human))
Daegu-Gyeongbuk Medical Innovation Foundation
Curated by ChEMBL
Daegu-Gyeongbuk Medical Innovation Foundation
Curated by ChEMBL
Affinity DataIC50: 190nMAssay Description:Inhibition of fluorescien-conjugated coactivator PGC1a binding to GST-tagged human ERRgamma LBD after 1 hr by TR-FRET assayMore data for this Ligand-Target Pair
TargetEstrogen-related receptor gamma(Homo sapiens (Human))
Daegu-Gyeongbuk Medical Innovation Foundation
Curated by ChEMBL
Daegu-Gyeongbuk Medical Innovation Foundation
Curated by ChEMBL
Affinity DataIC50: 270nMAssay Description:Inhibition of fluorescien-conjugated coactivator PGC1a binding to GST-tagged human ERRgamma LBD after 1 hr by TR-FRET assayMore data for this Ligand-Target Pair
TargetEstrogen-related receptor gamma(Homo sapiens (Human))
Daegu-Gyeongbuk Medical Innovation Foundation
Curated by ChEMBL
Daegu-Gyeongbuk Medical Innovation Foundation
Curated by ChEMBL
Affinity DataIC50: 480nMAssay Description:Inhibition of fluorescien-conjugated coactivator PGC1a binding to GST-tagged human ERRgamma LBD after 1 hr by TR-FRET assayMore data for this Ligand-Target Pair
TargetEstrogen-related receptor gamma(Homo sapiens (Human))
Daegu-Gyeongbuk Medical Innovation Foundation
Curated by ChEMBL
Daegu-Gyeongbuk Medical Innovation Foundation
Curated by ChEMBL
Affinity DataIC50: 480nMAssay Description:Inhibition of fluorescien-conjugated coactivator PGC1a binding to GST-tagged human ERRgamma LBD after 1 hr by TR-FRET assayMore data for this Ligand-Target Pair
TargetEstrogen-related receptor gamma(Homo sapiens (Human))
Daegu-Gyeongbuk Medical Innovation Foundation
Curated by ChEMBL
Daegu-Gyeongbuk Medical Innovation Foundation
Curated by ChEMBL
Affinity DataIC50: 500nMAssay Description:Inhibition of fluorescien-conjugated coactivator PGC1a binding to GST-tagged human ERRgamma LBD after 1 hr by TR-FRET assayMore data for this Ligand-Target Pair
TargetEstrogen-related receptor gamma(Homo sapiens (Human))
Daegu-Gyeongbuk Medical Innovation Foundation
Curated by ChEMBL
Daegu-Gyeongbuk Medical Innovation Foundation
Curated by ChEMBL
Affinity DataIC50: 520nMAssay Description:Inhibition of fluorescien-conjugated coactivator PGC1a binding to GST-tagged human ERRgamma LBD after 1 hr by TR-FRET assayMore data for this Ligand-Target Pair
TargetEstrogen-related receptor gamma(Homo sapiens (Human))
Daegu-Gyeongbuk Medical Innovation Foundation
Curated by ChEMBL
Daegu-Gyeongbuk Medical Innovation Foundation
Curated by ChEMBL
Affinity DataIC50: 669nMAssay Description:Inverse agonist activity at ERRgamma (unknown origin) expressed in human AD293 cells after 24 hrs by beta-galactosidase/luciferase reporter gene assa...More data for this Ligand-Target Pair
TargetEstrogen-related receptor gamma(Homo sapiens (Human))
Daegu-Gyeongbuk Medical Innovation Foundation
Curated by ChEMBL
Daegu-Gyeongbuk Medical Innovation Foundation
Curated by ChEMBL
Affinity DataIC50: 719nMAssay Description:Inverse agonist activity at ERRgamma (unknown origin) expressed in human AD293 cells after 24 hrs by beta-galactosidase/luciferase reporter gene assa...More data for this Ligand-Target Pair